BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 16442398)

  • 61. Joint effect of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol on the risk of coronary heart disease.
    Hu G; Cui Y; Jousilahti P; Sundvall J; Girman CJ; Antikainen R; Laatikainen T; Tuomilehto J
    Eur J Prev Cardiol; 2013 Feb; 20(1):89-97. PubMed ID: 22023802
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Triglycerides + high-density-lipoprotein-cholesterol dyslipidaemia, a coronary risk factor in elderly women: the CArdiovascular STudy in the ELderly.
    Mazza A; Tikhonoff V; Schiavon L; Casiglia E
    Intern Med J; 2005 Oct; 35(10):604-10. PubMed ID: 16207260
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Lipid profile components and incident cerebrovascular events versus coronary heart disease; the result of 9 years follow-up in Tehran Lipid and Glucose Study.
    Tohidi M; Mohebi R; Cheraghi L; Hajsheikholeslami F; Aref S; Nouri S; Azizi F; Hadaegh F
    Clin Biochem; 2013 Jun; 46(9):716-21. PubMed ID: 23531403
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effectiveness of a fenofibrate 145-mg nanoparticle tablet formulation compared with the standard 160-mg tablet in patients with coronary heart disease and dyslipidemia.
    Maciejewski S; Hilleman D
    Pharmacotherapy; 2008 May; 28(5):570-5. PubMed ID: 18447655
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile.
    Meas T; Laloi-Michelin M; Virally M; Peynet J; Giraudeaux V; Kévorkian JP; Guillausseau PJ
    Eur J Intern Med; 2009 Mar; 20(2):197-200. PubMed ID: 19327612
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lipoprotein abnormalities are associated with insulin resistance in South Asian Indian women.
    Palaniappan LP; Kwan AC; Abbasi F; Lamendola C; McLaughlin TL; Reaven GM
    Metabolism; 2007 Jul; 56(7):899-904. PubMed ID: 17570249
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Relative atherogenicity and predictive value of non-high-density lipoprotein cholesterol for coronary heart disease.
    Miller M; Ginsberg HN; Schaefer EJ
    Am J Cardiol; 2008 Apr; 101(7):1003-8. PubMed ID: 18359322
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A comparison of lipid variables as predictors of cardiovascular disease in the Asia Pacific region.
    Barzi F; Patel A; Woodward M; Lawes CM; Ohkubo T; Gu D; Lam TH; Ueshima H;
    Ann Epidemiol; 2005 May; 15(5):405-13. PubMed ID: 15840555
    [TBL] [Abstract][Full Text] [Related]  

  • 69. LDL-cholesterol as a determinant of coronary heart disease.
    Hunninghake D
    Clin Ther; 1990; 12(5):370-5; discussion 369. PubMed ID: 2268861
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serum lipid screening to identify high-risk individuals for coronary death. The results of the Lipid Research Clinics prevalence cohort.
    Grover SA; Palmer CS; Coupal L
    Arch Intern Med; 1994 Mar; 154(6):679-84. PubMed ID: 8129502
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A study of lipid profile before and after coronary artery bypass grafting.
    Ooi M; Cooper A; Lloyd G; Jackson G
    Br J Clin Pract; 1996 Dec; 50(8):433-5. PubMed ID: 9039713
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Association of leucine 7 to proline 7 polymorphism in the preproneuropeptide Y with serum lipids in patients with coronary heart disease.
    Erkkilä AT; Lindi V; Lehto S; Laakso M; Uusitupa MI
    Mol Genet Metab; 2002 Mar; 75(3):260-4. PubMed ID: 11914038
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Menopause and modifiable coronary heart disease risk factors: a population based study.
    Agrinier N; Cournot M; Dallongeville J; Arveiler D; Ducimetière P; Ruidavets JB; Ferrières J
    Maturitas; 2010 Mar; 65(3):237-43. PubMed ID: 20031345
    [TBL] [Abstract][Full Text] [Related]  

  • 74. High prevalence of low HDL-cholesterol in a pan-European survey of 8545 dyslipidaemic patients.
    Bruckert E; Baccara-Dinet M; McCoy F; Chapman J
    Curr Med Res Opin; 2005 Dec; 21(12):1927-34. PubMed ID: 16368042
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lipoproteins, cardiovascular disease, and death. The Framingham study.
    Gordon T; Kannel WB; Castelli WP; Dawber TR
    Arch Intern Med; 1981 Aug; 141(9):1128-31. PubMed ID: 7259370
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Lipid parameters and cardiovascular risks in elderly patients hospitalized for ischemic cardiopathy. A case-control study].
    Poli L; Bo M; Fonte G; Pedrazzini V; Gobbi C; Fabris F
    G Ital Cardiol; 1992 Sep; 22(9):1059-66. PubMed ID: 1291423
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study.
    Mackness B; Durrington P; McElduff P; Yarnell J; Azam N; Watt M; Mackness M
    Circulation; 2003 Jun; 107(22):2775-9. PubMed ID: 12756158
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lipid profile parameters in Malaysian dyslipidemic patients.
    Al-Khateeb A; Mohamed MS; Imran K; Ibrahim S; Zilfalil BA; Yusof Z
    Kobe J Med Sci; 2011 Dec; 57(2):E38-48. PubMed ID: 22926072
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A study to evaluate the relationship between periodontitis, cardiovascular disease and serum lipid levels.
    Sridhar R; Byakod G; Pudakalkatti P; Patil R
    Int J Dent Hyg; 2009 May; 7(2):144-50. PubMed ID: 19413548
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A prospective study of plasma lipid levels and hypertension in women.
    Sesso HD; Buring JE; Chown MJ; Ridker PM; Gaziano JM
    Arch Intern Med; 2005 Nov; 165(20):2420-7. PubMed ID: 16287773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.